Simon Rule

98PUBLICATIONS
348CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (98)

|Jul 13, 2026
Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.

|Jul 09, 2026
Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma.

|Jul 02, 2026
BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistance.

|Jul 01, 2026
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

|Jun 04, 2026
Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

|Apr 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

Pageof 17

Frequent Collaborators

19 joint publications

Preetesh Jain

10 joint publications

Sairah Ahmed

9 joint publications

Jason Westin

8 joint publications

Yang Liu